BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33962485)

  • 1. Transfusion support during childbirth for a woman with anti-U and the
    Yin Q; Srivastava K; Brust DG; Flegel WA
    Immunohematology; 2021 Mar; 37(1):1-4. PubMed ID: 33962485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles.
    Vege S; Sprogøe U; Lomas-Francis C; Jakobsen MA; Antonsen B; Aeschlimann J; Yazer M; Westhoff CM
    Transfusion; 2021 Jan; 61(1):256-265. PubMed ID: 32975828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion management of a Chinese pregnant woman with RHD*DEL1 allele.
    Liu C; Xue Y; Ouchari M; Yin Q
    Transfus Clin Biol; 2021 Aug; 28(3):293-295. PubMed ID: 33991666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion support for a woman with
    Srivastava K; Bueno MU; Flegel WA
    Immunohematology; 2022 Apr; 38(1):17-24. PubMed ID: 35852060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance and costs of RHD genotyping in women with a weak D phenotype.
    Laget L; Izard C; Durieux-Roussel E; Gouvitsos J; Dettori I; Chiaroni J; Ferrera-Tourenc V
    Transfus Clin Biol; 2019 Feb; 26(1):27-31. PubMed ID: 29866395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services.
    Ramsey G; Park YA; Eder AF; Bobr A; Karafin MS; Karp JK; King KE; Pagano MB; Schwartz J; Szczepiorkowski ZM; Souers RJ; Thomas L; Delaney M
    Arch Pathol Lab Med; 2023 Jan; 147(1):71-78. PubMed ID: 35486492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHD genotyping to resolve weak and discrepant RhD patient phenotypes.
    Barriteau CM; Lindholm PF; Hartman K; Sumugod RD; Ramsey G
    Transfusion; 2022 Nov; 62(11):2194-2199. PubMed ID: 36218305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization.
    Horn TN; Keller J; Keller MA; Klinger L
    Immunohematology; 2020 Dec; 36(4):146-151. PubMed ID: 33544620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RHD-negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen.
    Juhl D; Luckner K; Brockmann C; Musiolik I; Bunge-Philipowski T; Görg S; Ziemann M
    Transfusion; 2024 Feb; 64(2):281-288. PubMed ID: 38142051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.
    Sandler SG; Roseff SD; Domen RE; Shaz B; Gottschall JL
    Arch Pathol Lab Med; 2014 May; 138(5):620-5. PubMed ID: 24786120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
    Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype.
    Dezan MR; Oliveira VB; Gomes ÇN; Luz F; Gallucci AJ; Bonifácio SL; Alencar CS; Sabino EC; Pereira AC; Krieger JE; Rocha V; Mendrone-Junior A; Dinardo CL
    J Clin Lab Anal; 2018 Nov; 32(9):e22596. PubMed ID: 29943480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.
    Londero D; Monge J; Hellberg A
    Vox Sang; 2020 Apr; 115(3):241-248. PubMed ID: 31912520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
    Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
    Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with Asian-type DEL can safely be transfused with RhD-positive blood.
    Ji Y; Luo Y; Wen J; Sun Y; Jia S; Ou C; Yang W; Chen J; Ye H; Liu X; Liang Y; Lu Z; Feng Y; Wu X; Xiao M; Mo J; Zhou Z; Wang Z; Liao Z; Chen J; Wei L; Luo G; Santoso S; Fichou Y; Flegel WA; Shao C; Li C; Zhang R; Fu Y
    Blood; 2023 Apr; 141(17):2141-2150. PubMed ID: 36638337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rh Immunoprophylaxis for Women With a Serologic Weak D Phenotype.
    Virk M; Sandler SG
    Lab Med; 2015; 46(3):190-4. PubMed ID: 26199257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cases of RhD variants RhD*DAU2/DAU6 and RhD*weak D type 4.1 in pregnant women in Saudi Arabia.
    Owaidah A; Aljuhani K; Albasri J; Alsulmi E; Alsaihati T; Alzahrani F
    Acta Biomed; 2023 Mar; 94(S1):e2023080. PubMed ID: 36883669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic RHD genotyping in Brazilians reveals a high frequency of partial D in transfused patients serologically typed as weak D.
    Miranda MR; Dos Santos TD; Castilho L
    Transfus Apher Sci; 2021 Dec; 60(6):103235. PubMed ID: 34389204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rh Immune Globulin After the Transfusion of RhD-Positive Blood in a Patient with a Partial D Antigen.
    Lesser TH; O'Malley M; Ehsanipoor RM
    Obstet Gynecol; 2022 Dec; 140(6):1052-1055. PubMed ID: 36357991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.
    Sandler SG; Chen LN; Flegel WA
    Br J Haematol; 2017 Oct; 179(1):10-19. PubMed ID: 28508413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.